Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Celltrion/Nippon Kayaku Herceptin Biosimilars Get OK for New Breast Cancer Dosing Schedule
August 22, 2019
- GSK’s Daprodustat Reaches 1st NDA Filing, in Japan
August 22, 2019
- NEDO to Subsidize Development of FunPep’s Antibody-Inducing Peptide for Psoriasis Treatment
August 22, 2019
- Tomita Pharmaceutical Invests in Wearable Medical Device Startup
August 22, 2019
- Frontloaded Price Cuts before Regular April Revision Hurts, Say Drug Makers
August 21, 2019
- Teva Takeda to License 10 APIs/20 Products from Sawai as It Plans to Shutter In-House Plants
August 21, 2019
- Big 3 Generic Players Braced for Average 9.2% Price Cut in October Re-Pricing
August 20, 2019
- Tax Hike Re-Pricing Slams Small Pharma and Gx Players, Impact Milder for Big Firms: Survey
August 20, 2019
- Sumitomo Dainippon Flip-Plops on Sales Force Cutback as It Ramps Up Diabetes Push
August 19, 2019
- Pharmacist Average Monthly Salary Down 9,636 Yen: Survey
August 19, 2019
- Osaka Univ. Spinout StemRIM Makes Tepid TSE Debut
August 16, 2019
- Towa Starts Joint Research with National CV Center on Disease Prevention, Healthy Life Expectancy Extension
August 16, 2019
- AstraZeneca Japan Adjusts Company Rules for Same-Sex, Common-Law Couples
August 16, 2019
- Otsuka Rings Up Double-Digit Growth in H1 Pharma Sales
August 9, 2019
- Takeda Seeks Japan Approval for Entyvio SC Form
August 9, 2019
- Ono Seeks Label Expansion for Onoact Sepsis-Associated Tachyarrhythmia
August 9, 2019
- Mitsubishi Tanabe’s Schizophrenia Drug Cariprazine Approved in 2 Asian Nations
August 9, 2019
- Mitsubishi Tanabe Submits PI Study Protocol for Spinal Cord Injury Treatment MT-3921 in US
August 9, 2019
- Sumitomo Dainippon Going Full Tilt for Napabucasin Colorectal Cancer Trial after Pancreatic Flop
August 8, 2019
- Mitsubishi Tanabe’s ALS Drug Gains Chinese Approval
August 8, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…